Please login to the form below

Ashfield announces leadership changes in the U.S. and Japan.

Ashfield announces the appointment of Greg Flynn as Regional President of Commercial and Clinical in the U.S. and Mick O’Leary as Regional President of Commercial and Clinical in Japan, where he will lead CMIC Ashfield.

Greg Flynn will oversee U.S. operations of Commercial, Clinical, Medical Information, Pharmacovigilance and Market Access. Greg is transitioning to this role from his prior position as Regional President in Japan and Representative Director of CMIC Ashfield, a joint initiative between CMIC Holdings Co., Ltd and UDG Healthcare plc. Under Greg’s leadership, Ashfield became an industry leading partner with over 650 staff across 44 clients in five years.



Mick O’Leary will take over the role as Regional President in Japan, leading the CMIC Ashfield joint venture. Mick was previously the Managing Director for Ashfield Ireland, and has over 20 years’ experience in the pharmaceutical sales industry. Under Mick’s leadership, Ashfield has been established as the Number 1 CSO in Ireland with over 60% market share.



Commenting on his appointment, Greg Flynn said: “Through the talent of our people and Ashfield’s commitment to helping improve lives, I have seen the power of what we do in this organisation. The U.S. business has experienced phenomenal growth in the last two years and this new role is an exciting opportunity to continue that growth. I am excited about the future of Ashfield in the U.S. and being part of the next phase in this company’s journey.”

Mick O’Leary commented, “I am delighted to accept the role of Regional President in Japan and support the group’s overall strategy of expansion in growth markets. CMIC Ashfield is a winning proposition, combining the experience and expertise of a leading international CSO, with the local knowledge and capability of one of Japan’s leading CSOs. We’ll continue to excel by providing flexible, evidence-based services and I look forward to working with new clients and brand challenges in Japan.”

Julian Tompkins, Global President for Ashfield Clinical and Commercial business also commented: “We are delighted to have appointed these critical roles for the business. Greg’s leadership in the Japanese market has yielded remarkable growth and proven his dedication to Ashfield’s success. With Greg’s innovative thinking and focus on people, we are looking forward to seeing his impact on the U.S. business.

The appointment of Mick O’Leary as Regional President in Japan will continue our success story and excellent results in the second largest global pharmaceutical market. He has exactly the right expertise and drive to lead CMIC Ashfield and continue our strong progress in Japan.”

For more information on Ashfield services visit ashfieldhealthcare.com or for questions on this article contact jane.neale@ashfieldhealthcare.com.


15th June 2017

Share

Company Details

Ashfield

Contact Website

Address:
Ashfield House
Resolution Road
Ashby de la Zouch
Leicestershire
LE65 1HW
UK

Latest content on this profile

Ashfield to host global webinar on Patient Service Team on 10 July
We’re hosting a one-hour webinar, “Challenging the conventional commercial model” to share this patient-centric approach that delivers value to patients, prescribers and office teams. Presented by John Gerow, Service Team Strategy Partner, Ashfield, this presentation will explain the reason so many of our clients are adopting this approach with their existing field sales strategies.
Ashfield
Jo Fearnhead-Wymbs A year in the role as patient engagement director
A year of patient-cenricity… helping our clients have an even greater impact on patient outcomes
Ashfield
Ashfield announces leadership changes in the U.S. and Japan.
Ashfield announces the appointment of Greg Flynn as Regional President of Commercial and Clinical in the U.S. and Mick O’Leary as Regional President of Commercial and Clinical in Japan, where he will lead CMIC Ashfield.
Ashfield
Pegasus unveils new brand identity as it celebrates a year as part of Ashfield.
Pegasus, has unveiled a new brand identity signaling its successful integration with the global business, a year on from acquisition. Conceived by Pegasus’s in-house creative services team, the new look now lives across its internal and external channels.
Ashfield
Ashfield wins Analyst Team of the Year at the UK Best of Business Intelligence (BOBI) Awards 2017.
We are thrilled to announce that our Business Intelligence Team walked away with the Analyst Team of the Year Award at the 2017 BOBI Awards, which took place in London on Monday 8 May.
Ashfield
Ashfield Healthcare Communications expands across the UK and Europe
Ashfield Healthcare Communications signals significant growth with new office openings in Dublin and Glasgow.
Ashfield